Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Previous Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development You Might Also Like Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications AI-Driven Patient Identification and Recruitment
Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Previous Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development You Might Also Like Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications AI-Driven Patient Identification and Recruitment
